Novavax, Inc. Made Headway
Tue, May 12, 2020 at 05:30 PM
Novavax, Inc. (NVAX:NASDAQ) soared at $39.82, a gain of 62.5%. On Mon 11 May 20, NVAX:NASDAQ touched a New 2-Week High of $24.5. The stock appeared on our News Catalysts scanner on Sat 02 May 20 at 04:56 AM in the 'INVESTOR UPDATE' category. From Mon 27 Apr 20, the stock recorded 40.00% Up Days and 45.45% Green Days
The stock spiked on Mon 20 Apr 20 at $26.34 with a volume of 27M+.
About Novavax, Inc. (NVAX:NASDAQ)
Novavax Inc is a clinical-stage vaccine company. It is engaged in the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants.
Top 10 Gainers:
- CymaBay Therapeutics, Inc. (CBAY:NASDAQ), 127.17%
- Novavax, Inc. (NVAX:NASDAQ), 62.53%
- Rand Capital Corporation (RAND:NASDAQ), 43.07%
- Super League Gaming, Inc. (SLGG:NASDAQ), 41.3%
- Babcock & Wilcox Enterprises, Inc. (BW:NYSE), 40.26%
- Gamida Cell Ltd. (GMDA:NASDAQ), 36.56%
- Naked Brand Group Limited (NAKD:NASDAQ), 34.62%
- VectoIQ Acquisition Corp. (VTIQ:NASDAQ), 32.97%
- Ritter Pharmaceuticals, Inc. (RTTR:NASDAQ), 32.33%
- Grubhub Inc. (GRUB:NYSE), 29.07%